BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23695449)

  • 1. Galectins in hematological malignancies.
    Giordano M; Croci DO; Rabinovich GA
    Curr Opin Hematol; 2013 Jul; 20(4):327-35. PubMed ID: 23695449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Galectins in hematological malignancies--role, functions and potential therapeutic targets].
    Wdowiak K; Spychałowicz W; Fajkis M; Wojnar J
    Postepy Hig Med Dosw (Online); 2016 Feb; 70():95-103. PubMed ID: 26943306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectins: structure, function and therapeutic potential.
    Yang RY; Rabinovich GA; Liu FT
    Expert Rev Mol Med; 2008 Jun; 10():e17. PubMed ID: 18549522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of galectins in the initiation, amplification and resolution of the inflammatory response.
    Rubinstein N; Ilarregui JM; Toscano MA; Rabinovich GA
    Tissue Antigens; 2004 Jul; 64(1):1-12. PubMed ID: 15191517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model.
    Demers M; Biron-Pain K; Hébert J; Lamarre A; Magnaldo T; St-Pierre Y
    Cancer Res; 2007 Mar; 67(6):2824-9. PubMed ID: 17363605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectins and microenvironmental niches during hematopoiesis.
    Rabinovich GA; Vidal M
    Curr Opin Hematol; 2011 Nov; 18(6):443-51. PubMed ID: 21912250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
    Saussez S; Camby I; Toubeau G; Kiss R
    Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma.
    Wollina U; Graefe T; Feldrappe S; André S; Wasano K; Kaltner H; Zick Y; Gabius HJ
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):103-10. PubMed ID: 11862481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The galectin family and digestive disease.
    Demetter P; Nagy N; Martin B; Mathieu A; Dumont P; Decaestecker C; Salmon I
    J Pathol; 2008 May; 215(1):1-12. PubMed ID: 18335458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular galectins as controllers of cytokines in hematological cancer.
    Gordon-Alonso M; Bruger AM; van der Bruggen P
    Blood; 2018 Aug; 132(5):484-491. PubMed ID: 29875102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.
    Sioud M; Mobergslien A; Boudabous A; Fløisand Y
    Int J Oncol; 2011 Feb; 38(2):385-90. PubMed ID: 21165555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer.
    Rabinovich GA; Liu FT; Hirashima M; Anderson A
    Scand J Immunol; 2007; 66(2-3):143-58. PubMed ID: 17635792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype.
    Moisan S; Demers M; Mercier J; Magnaldo T; Potworowski EF; St-Pierre Y
    Leukemia; 2003 Apr; 17(4):751-9. PubMed ID: 12682633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectins: regulators of acute and chronic inflammation.
    Liu FT; Rabinovich GA
    Ann N Y Acad Sci; 2010 Jan; 1183():158-82. PubMed ID: 20146714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectins as regulators of cell survival in the leukemia niche.
    Ruvolo PP
    Adv Biol Regul; 2019 Jan; 71():41-54. PubMed ID: 30245264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectins in apoptosis.
    Hsu DK; Yang RY; Liu FT
    Methods Enzymol; 2006; 417():256-73. PubMed ID: 17132510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of galectins in tumor immunity: strategies and methods.
    Cerliani JP; Dalotto-Moreno T; Compagno D; Dergan-Dylon LS; Laderach DJ; Gentilini L; Croci DO; Méndez-Huergo SP; Toscano MA; Salatino M; Rabinovich GA
    Methods Mol Biol; 2015; 1207():249-68. PubMed ID: 25253145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varied expression and localization of multiple galectins in different cancer cell lines.
    Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
    Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Galectins in Multiple Myeloma.
    Storti P; Marchica V; Giuliani N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.